在运动前后,在马匹中进行宁-氨-阿尔多斯特系统剖析
Todd Holbrook1, Jorge Hernandez1, Taralyn McCarrel1
1College of Veterinary Medicine, University of Florida, Gainesville, Florida, USA.
Journal of veterinary internal medicine
|March 6, 2025
概括
运动可以激活马的古典和替代性氨酸 - 血管酶 - 氨系统 (RAAS) 途径. 这两种途径都显示在体力炼后代谢物和酶活性增加.
科学领域:
- 马类生理学 马类生理学
- 心血管研究的心血管研究.
- 内分泌学 在内分泌学.
背景情况:
- 运动对马的氨酸-血管酶-氨系统 (RAAS) 的影响在很大程度上仍未得到研究.
- 了解RAAS通路对运动的反应对于马的健康和表现至关重要.
研究的目的:
- 为了确定运动是否激活马匹的经典和替代RAAS通路.
- 为了比较耐力和高强度运动之间的经典RAAS路径的激活.
主要方法:
- 25匹马的血液样本在四种不同的运动方案之前和之后被采集.
- 用平衡分析测量RAAS途径的血清代谢物和酶活性.
- 进行了运动前和运动后值的比较,以及不同运动组之间的比较.
主要成果:
- 在所有马匹中,运动显著增加了经典RAAS代谢物 (angiotensin I, angiotensin II, aldosterone) 和替代RAAS代谢物 (angiotensin 1-7, angiotensin 1-5).
- 血管氨酸转化酶-2的活性也在运动后显著增加.
- 与耐力 (A-E) 和跑步机运动 (TB-TM) 相比,在经历短时间,高强度赛车 (TB-R) 的马中,血管新生素1-7比率显著更高.
结论:
- 经典和替代RAAS通路都通过运动激活马.
- 运动显著影响RAAS代谢物水平和酶活性.
- 不同的运动类型可能会在RAAS中引起不同的反应,特别是关于替代途径.
相关概念视频
Hormonal Regulation
32.8K
The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
32.8K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
360
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
360
Hormonal Regulation of Blood Pressure
2.3K
Endocrinal or hormonal intervention in the cardiovascular system is predominantly exerted by the catecholamines - epinephrine and norepinephrine, as well as a slew of hormones that interact with renal function to modulate blood volume.
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction...
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction...
2.3K
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
440
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
440
Antihypertensive Drugs: Direct Renin Inhibitors
468
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
468
Hypertension and Regulation of Blood Pressure
1.9K
Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
1.9K


